SCHEMBL3580056

SCHEMBL3580056

NCC1CCN(CC2CCNCC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.43
GBA1 P04062 2/20 0.41
GNAO1 P09471 1/20 0.40
CHRM5 P08912 1/20 0.39
ADRA2C P18825 1/20 0.39
CACNA2D1 P54289 1/20 0.38
CACNA1B Q00975 1/20 0.38
CACNB1 Q02641 1/20 0.38
ACHE P22303 3/20 0.38
CXCR4 P61073 1/20 0.38
HTR4 Q13639 1/20 0.38
SIGMAR1 Q99720 1/20 0.35
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015324 0.85 NCF1 (0.52) NCF1CHRM5ADRA2CACHECXCR4
Hydrochloric Acid SCHEMBL29653378 0.83 NCF1 (0.50) NCF1CHRM5ADRA2CACHECXCR4
SCHEMBL14422030 0.83 GBA1 (0.48) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL16303417 0.82 GBA1 (0.50) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL22940151 0.82 GBA1 (0.42) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL4031644 0.82 GBA1 (0.42) GBA1GNAO1CHRM5ADRA2CCACNA2D1
Hydrochloric Acid SCHEMBL5573130 0.81 GBA1 (0.47) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL2570307 0.81 GBA1 (0.47) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL12717723 0.80 GNAO1 (0.47) GBA1GNAO1CHRM5ADRA2CCACNA2D1
SCHEMBL134511 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660069-B1 FAST CURING EPOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2024-01-03 EP claimed
CN-111234182-A Fast curing epoxy system 赢创运营有限公司 2020-06-05 CN claimed
US-20200172723-A1 FAST-CURING EPOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2020-06-04 US claimed
EP-3660069-A1 FAST CURING EPOXY SYSTEMS Evonik Operations GmbH (DE) 2020-06-03 EP claimed
EP-3660069-B1 FAST CURING EPOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2024-01-03 EP disclosed
US-11254655-B2 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists THERAVANCE BIOPHARMA R&D IP, LLC (US) 2022-02-22 US disclosed
US-20200283408-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2020-09-10 US disclosed
US-10696656-B2 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists THERAVANCE BIOPHARMA R&D IP, LLC (US) 2020-06-30 US disclosed
CN-111234182-A Fast curing epoxy system 赢创运营有限公司 2020-06-05 CN disclosed
US-20200172723-A1 FAST-CURING EPOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2020-06-04 US disclosed
EP-3660069-A1 FAST CURING EPOXY SYSTEMS Evonik Operations GmbH (DE) 2020-06-03 EP disclosed
US-20190152951-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2019-05-23 US disclosed
EP-1899324-B1 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists THERAVANCE INC (US) 2011-11-30 EP disclosed
US-20100249186-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE BIOPHARMA R&D IP, LLC 2010-09-30 US disclosed
US-7759363-B2 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists THERAVANCE, INC. (US) 2010-07-20 US disclosed
US-20090209582-A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists THERAVANCE BIOPHARMA R&D IP, LLC 2009-08-20 US disclosed
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP disclosed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO disclosed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO disclosed
US-20060270652-A1 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists THERAVANCE, INC. 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283408-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS HTR4, HTR1A, HTR5A NCF1 2327/4885GBA1 1393/4885GNAO1 399/4885
US-20090209582-A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists HTR4, HTR1A, HTR5A NCF1 2194/4885GBA1 1105/4885GNAO1 464/4885
US-20100249186-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS HTR4, HTR1A, HTR5A NCF1 2327/4885GBA1 1393/4885GNAO1 399/4885
US-11254655-B2 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists HTR4, HTR1A, HTR5A NCF1 2327/4885GBA1 1393/4885GNAO1 399/4885
US-10696656-B2 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists HTR4, HTR1A, HTR5A NCF1 2327/4885GBA1 1393/4885GNAO1 399/4885
US-20060270652-A1 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists HTR4, HTR1A, HTR5A NCF1 2406/4885GBA1 1524/4885GNAO1 412/4885
US-20190152951-A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS HTR4, HTR1A, HTR5A NCF1 2327/4885GBA1 1393/4885GNAO1 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.